93 7330 Pill - yellow round, 9mm
Generic Name: fenofibrate
Pill with imprint 93 7330 is Yellow, Round and has been identified as Lofibra 54 mg. It is supplied by Teva Pharmaceuticals USA.
Lofibra is used in the treatment of Hyperlipoproteinemia Type IIa, Elevated LDL; Hypertriglyceridemia; Hyperlipoproteinemia; Hyperlipoproteinemia Type IIb, Elevated LDL VLDL; Hyperlipoproteinemia Type IV, Elevated VLDL and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 54 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7330
Lofibra
- Generic Name
- fenofibrate
- Imprint
- 93 7330
- Strength
- 54 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 57844-0691 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
ferric oxide yellow,
lactose monohydrate,
soya lecithin,
microcrystalline cellulose,
povidone k25,
povidone k30,
sodium lauryl sulfate,
sodium starch glycolate type A potato,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide,
xanthan gum,
D&C Yellow No. 10
Note: Inactive ingredients may vary.
Related images for "93 7330"
More about Lofibra (fenofibrate)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: fibric acid derivatives
- Breastfeeding
Patient resources
Other brands
TriCor, Triglide, Antara, Fenoglide, Lipofen
Professional resources
Other brands
TriCor, Triglide, Antara, Fenoglide, Lipofen
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
